News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
John Swartley, MBA, PhD, Penn’s Chief Innovation Officer, was named as a finalist for BioBuzz Leader of the Year in Greater Philadelphia.
These findings could pave the way for personalized treatments, matching patients to drugs based on their tumor's speckle pattern.
The technology addresses a critical health equity gap for pregnant individuals with preeclampsia.
iECURE reported preliminary findings from the first infant dosed with its in vivo gene editing candidate ECUR-506.
Sahay AI won the 1682 Venture Award, a pitch competition for early-stage AI-driven startups based in Philadelphia.
The goal of the NSF AIRFoundry is to make cutting-edge RNA research accessible to the broader scientific community to empower scientists to tackle some of the world’s biggest challenges,
ViTToria has dosed the first patient in its Phase 1 clinical trial for VIPER-101.
āshibio announced the dosing of the first participant in its Phase 2/3 clinical trial for its lead candidate, andecaliximab.
Cogwear was listed as one of PHL Inno’s Startups to Watch.
Interius was recognized in the Philadelphia Business Journal’s “PHL Inno 2024 in Review” as one of the top Philadelphia-area startups raising capital last year.